Literature DB >> 7346970

Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders.

P L Tan, G B Borman, R D Wigley.   

Abstract

The American Rheumatism Association (ARA) clinical criteria have been tested in systemic lupus erythematosus (SLE), progressive systemic sclerosis, polyarteritis nodosa and polymyositis/dermatomyositis. Hospital admissions from a defined population over the same period were studied. Increased weighting of the scores for the features showing the greatest specificity is suggested. These features are discoid lupus, alopecia, photosensitivity, LE cells and/or antinuclear antibody (ANA) and oral ulcers. Inclusion of histological evidence increased the sensitivity of the SLE scores.

Entities:  

Mesh：

Year:  1981        PMID： 7346970     DOI： 10.1007/bf00541261

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  5 in total

1.  Testing the 'preliminary criteria for classification of SLE'.

Authors:  J F Fries; R C Siegel
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

2.  Medical geography and the aetiology of the rare connective tissue diseases in New Zealand.

Authors:  R Wigley; B Borman
Journal:  Soc Sci Med Med Geogr       Date:  1980-06

3.  On the critical assessment and clinical applicability of the rheumatology literature.

Authors:  P Tugwell; D L Sackett; R B Haynes
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666

4.  A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1979-08

5.  Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis.

Authors:  H Lom-Orta; D Alarcon-Segovia; E Diaz-Jouanen
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666
  5 in total
  3 in total

1.  FCGR3A V(176) polymorphism for systemic lupus erythematosus susceptibility in Mexican population.

Authors:  Aniel J L Brambila-Tapia; Jorge I Gámez-Nava; Laura González-López; Lucila Sandoval-Ramírez; Julio Medína-Díaz; Montserrat Maldonado; Sergio R Gutierrez-Ureña; Gloria Martínez-Bonilla; Beatriz T Martín-Márquez; Mónica Vázquez Del Mercado; Arnulfo Nava-Zavala; José F Muñoz-Valle; Mario Salazar-Páramo; Ingrid P Dávalos-Rodríguez
Journal:  Rheumatol Int       Date:  2010-03-24       Impact factor: 2.631

2.  CD28 proximal promoter polymorphisms in systemic lupus erythematosus susceptibility.

Authors:  Aniel Jessica Leticia Brambila-Tapia; Ingrid P Dávalos-Rodríguez; Jorge Iván Gámez-Nava; Laura González-López; Julio Medina-Díaz; Ana Guilaisne Bernard-Medina; Mario Salazar-Páramo
Journal:  Rheumatol Int       Date:  2011-05-05       Impact factor: 2.631

3.  Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.

Authors:  Mohamed Ismail Abd-Elkareem; Hegazy Mogahed Al Tamimy; Osama A Khamis; Salama S Abdellatif; Mahmoud Rezk Abdelwahed Hussein
Journal:  Clin Exp Nephrol       Date:  2010-08-17       Impact factor: 2.801
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.